Works matching IS 20050380 AND DT 2024 AND VI 35 AND IP 6

Results: 21

Genetic analysis of cervical cancer with lymph node metastasis.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e102

By:

Hao He;
Misi He;
Qi Zhou;
Ying Tang;
Jing Wang;
Xiuying Li;
Dongling Zou

Publication type:

Article

Erratum: Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer.

Published in:: Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e118
Publication type:: Article

Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e113

By:

Munetaka Takekuma;
Koji Matsuo;
Shinya Matsuzaki;
Mitsuya Ishikawa;
Toyomi Satoh

Publication type:

Article

A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial hyperplasia: Japanese Gynecologic Oncology Group study (JGOG2051/KGOG2031, REMPA trial)

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e106

By:

Kensuke Sakai;
Wataru Yamagami;
Yasunori Sato;
Nobuyuki Susumu;
Yoshihito Yokoyama;
Kazuhiro Takehara;
Masaki Mandai;
Aikou Okamoto

Publication type:

Article

Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e105

By:

Min-Hyun Baek;
Lei Chen;
Cumhur Tekin;
Cristescu, Razvan;
Xiao Yang Jin;
Changxia Shao;
Soo Yeon Ihm;
Jelinic, Petar;
Jeong-Yeol Park

Publication type:

Article

Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e103

By:

Risako Ozawa;
Tadaaki Nishikawa;
Hiroshi Yoshida;
Kouya Shiraishi;
Tatsunori Shimoi;
Tomoyasu Kato;
Kan Yonemori

Publication type:

Article

Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e117

By:

Kwon, Janice S.;
McTaggart-Cowan, Helen;
Ferguson, Sarah E.;
Samouëlian, Vanessa;
Lambaudie, Eric;
Guyon, Frédéric;
Tidy, John;
Williamson, Karin;
Gleeson, Noreen;
de Kroon, Cor;
van Driel, Willemien;
Mahner, Sven;
Hanker, Lars;
Goffin, Frédéric;
Berger, Regina;
Eyjólfsdóttir, Brynhildur;
Jae-Weon Kim;
Brotto, Lori A.;
Pataky, Reka;
Yeung, Shirley S. T.

Publication type:

Article

The prognostic significance of primary tumor site in vulvar cancer: a population-based cohort study.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e101

By:

Penglin Liu;
Xuechao Ji;
Zhuang Li;
Wenzhi Kong;
Zangyu Pan;
Mengqi Deng;
Jinwei Miao

Publication type:

Article

Efficacy and safety of combined anlotinib-oral etoposide treatment for patients with platinum-resistant ovarian cancer.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e100

By:

Shuai Huang;
Guihua Sheng;
Qiubo Lv;
Ye Li;
Qingwei Meng;
Xuexiao Gao;
Zhiyuan Shang

Publication type:

Article

Cost-effectiveness of pembrolizumab plus chemotherapy for advanced endometrial cancer.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e86

By:

Gengwei Huo;
Ying Song;
Peng Chen

Publication type:

Article

Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e85

By:

Termrungruanglert, Wichai;
Khemapech, Nipon;
Vasuratna, Apichai;
Havanond, Piyalamporn;
Tantitamit, Tanitra

Publication type:

Article

Prognostic values of tumor size and location in early stage endometrial cancer patients who received radiotherapy.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e84

By:

Shuning Jiao;
Lichun Wei;
Lijuan Zou;
Tiejun Wang;
Ke Hu;
Fuquan Zhang;
Xiaorong Hou

Publication type:

Article

The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e80

By:

Young Joo Lee;
Woojin Kim;
Soomin Hong;
Yong Jae Lee;
Jung-Yun Lee;
Sang Wun Kim;
Sunghoon Kim;
Young Tae Kim;
Eun Ji Nam

Publication type:

Article

SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinoma.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e79

By:

Yalong Deng;
Lu Zhang;
Changyuan Dai;
Yan Xu;
Qiyu Gan;
Jingxin Cheng

Publication type:

Article

Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e78

By:

Yu-Wei Chang;
Hsiao-Li Kuo;
Tzu-Chien Chen;
Jessica Chen;
Ling Lim;
Kung-Liahng Wang;
Jen-Ruei Chen

Publication type:

Article

QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e77

By:

Cheng Fang;
Yun Zhou;
Yanling Feng;
Liping He;
Jinjin Yu;
Yuzhi Li;
Mei Feng;
Mei Pan;
Lina Zhao;
Dihong Tang;
Xiumin Li;
Buzhen Tan;
Ruifang An;
Xiaohui Zheng;
Meimei Si;
Baihui Zhang;
Lingyan Li;
Xiaoyan Kang;
Qi Zhou;
Jihong Liu

Publication type:

Article

A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e76

By:

Hiromi Komazaki;
Kazuaki Takahashi;
Hiroshi Tanabe;
Yuichi Shoburu;
Misato Kamii;
Akina Tsuda;
Motoaki Saito;
Kyosuke Yamada;
Hirokuni Takano;
Hirofumi Michimae;
Aikou Okamoto

Publication type:

Article

Influence of cancer in pregnancy on obstetric and neonatal outcomes: an observational retrospective cohort study.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e74

By:

Xuan Huang;
Chen Zhang;
Jialei Zhu;
Yueyan Li;
Jing Tang

Publication type:

Article

Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e73

By:

Young Joo Lee;
Yoon Kyung Shin;
Nae Ry Kim;
Se Ik Kim;
Yoo-Young Lee;
Jeong-Yeol Park;
Jae-Weon Kim;
Hyun-Woong Cho;
Jung-Yun Lee

Publication type:

Article

Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e72

By:

Eun Hye Cho;
Min-Seung Park;
Hee-Yeon Woo;
Hyosoon Park;
Min-Jung Kwon

Publication type:

Article

Mirvetuximab soravtansine in platinum-resistant recurrent ovarian cancer with high folate receptor-alpha expression: a cost-effectiveness analysis.

Published in:

Journal of Gynecologic Oncology, 2024, v. 35, n. 6, p. 1, doi. 10.3802/jgo.2024.35.e71

By:

Youwen Zhu;
Yinxin Lin;
Kun Liu;
Hong Zhu

Publication type:

Article